Piper Sandler Bullish on Tango Therapeutics’ Futureby Mark Eisenberg 12.02.2024Tango Therapeutics receives positive coverage from Piper Sandler, emphasizing its strong position in precision oncology. The firm believes the company's ...
Bristol Myers Bags RayzeBio in $4.1B Cancer Fight Pactby Mark Eisenberg 12.02.2024Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
AN2 Therapeutics Pauses Trial: Efficacy Concerns Riseby Mark Eisenberg 12.02.2024AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...
Unlearn Receives Funding for Clinical Trial Digital Twin Techby Lilu Anderson 09.02.2024AI company Unlearn has secured $50m in funding to develop AI solutions that create digital twins for trial participants, helping ...
Regeneron: Seize the Opportunity and Reap the Benefitsby Mark Eisenberg 12.01.2024RBC Capital upgrades Regeneron to Outperform, raises price target to $1,076 from $884, citing its prolific R&D engine and recent ...
Investing in Psychedelics for Net Zero Traumaby Mark Eisenberg 11.01.2024Investors are turning to psychedelics as a game-changer for mental health. The recent $100 million financing for Lykos Therapeutics shows ...
New App Reduces Tinnitus Impact, Say Researchersby Lilu Anderson 09.01.2024A new app called MindEar offers relief for tinnitus sufferers by providing cognitive behavioral therapy (CBT) through a chatbot and ...
AI Apps Diagnose Coughs: Revolutionizing Healthcareby Lilu Anderson 05.01.2024A smartphone app using AI to analyze cough sounds shows promise in diagnosing TB, offering a valuable screening tool in ...
Exploring Biotech ETFs: Investing in Medical Breakthroughsby Mark Eisenberg 05.01.2024Biotech ETFs offer investors a way to access the potential gains of the biotech industry. From breakthrough medicines to innovative ...